Across America, hospitals have been grappling with an acute shortage of blood culture bottles, pivotal in diagnosing serious, potentially fatal bloodstream infections. The Centers for Disease Control and Prevention issued a warning to health care professionals, lab specialists, health facility administrators, and state, tribal, and local health bodies, cautioning the shortage of Bactec blood culture medium bottles, a product line of Becton Dickinson. This shortage has endured for several weeks, with a potential continuation into September.
Blood culture bottles play a fundamental role in any healthcare provider’s endeavor to identify the cause of a bloodstream infection and determine the appropriate treatment. For instance, Staphylococcus aureus bacteria can trigger such infections. Lack of ability to detect pathogens or their susceptibility to specific antibiotics increases the risk of antibiotic resistance and leads to complications like Clostridium difficile-associated diarrhea, warns Krutika Kuppalli, a spokesperson for the Infectious Diseases Society of America.
During a webinar hosted by CDC and IDSA, experts discussed the impact of this critical shortage. Some institutions might deplete their bottle supplies entirely. Romney Humphries, the Medical Director of the microbiology laboratory at Vanderbilt University Medical Center, stated that the situation was far from ideal for patients. The hospital had received a mere 10 bottles in the week. Hospitals are resorting to cost-saving methods such as lowering the number of blood culture tests and exploring the potential of safely using expired bottles.
Sarah Turbett, the associate director of clinical microbiology laboratories at Massachusetts General Hospital, noted that these strategies seem effective as no difference in bacterial growth time was detected between expired and non-expired bottles during her team’s tests. However, FDA’s stance on the usage of expired bottles remains unclear. Chris Beddard, Vice President of Microbiology at BD, revealed that the company relies on a singular supplier for the Bactec bottles, who, for the last 12 years, has been a dependable source. Andrew Pavia, chief of pediatric infectious diseases at the University of Utah, stressed the importance of blood cultures in treating infectious diseases.
In conclusion, the gravity of the shortage calls for careful consideration, flexibility, and an informed approach to mitigate its potential impact on patient care. As the situation continues to evolve, it is clear that the healthcare sector must prepare for a potentially worse-than-forecasted shortage.
Source: https://www.statnews.com/2024/07/23/blood-culture-bottle-shortage-cdc-alert-becton-dickinson/